Oramed Pharmaceuticals Inc. (ORMP) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.15
Day's range
$3.28

Oramed Pharmaceuticals, Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BML CAPITAL MANAGEMENT, LLC 05/06/2026 3.17 M $10.77 M   0.00% 7.65%
05/15/2026 2.11 M $7.18 M   7.06% 5.10%
MERCER GLOBAL ADVISORS INC /ADV 05/15/2026 1.91 M $6.50 M   100.00% 4.61%
GEM INVESTMENT ADVISORS, LLC 05/15/2026 1.64 M $5.58 M   -17.95% 3.96%
MURCHINSON LTD. 05/15/2026 1.32 M $4.47 M   -1.86% 3.18%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 600.72 K $2.04 M   -1.87% 1.45%
MARSHALL WACE, LLP 05/15/2026 259.61 K $882.68 K   0.21% 0.63%
RATHBONES GROUP PLC 06/09/2026 233.02 K $792.26 K   0.00% 0.56%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 158.21 K $537.74 K   5.14% 0.38%
WELLS FARGO & COMPANY/MN 05/11/2026 157.59 K $535.79 K   20.68% 0.38%
RITHOLTZ WEALTH MANAGEMENT 04/20/2026 155.48 K $528.63 K   100.00% 0.38%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 147.70 K $502.18 K   0.14% 0.36%
BANK OF AMERICA CORP /DE/ 05/18/2026 146.15 K $496.92 K   2.75% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 136.22 K $463.14 K   424.24% 0.33%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 05/13/2026 116.36 K $395.63 K   100.00% 0.28%
CITADEL ADVISORS LLC 05/15/2026 98.63 K $335.34 K   -49.68% 0.24%
HILLSDALE INVESTMENT MANAGEMENT INC. 05/04/2026 97.30 K $330.82 K   100.00% 0.24%
BLACKROCK, INC. 05/13/2026 92.19 K $313.45 K   2.19% 0.22%
JANE STREET GROUP, LLC 05/12/2026 52.54 K $178.64 K   -32.86% 0.13%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 51.67 K $175.68 K   100.00% 0.12%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 50.21 K $170.70 K   14.80% 0.12%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2026 35.31 K $120.06 K   63.39% 0.09%
BAILARD, INC. 05/11/2026 32.48 K $110.43 K   100.00% 0.08%
AMERICAN CENTURY COMPANIES INC 05/15/2026 32.31 K $109.84 K   64.91% 0.08%
HRT FINANCIAL LP 05/14/2026 27.50 K $93.00 K   -40.34% 0.07%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 26.05 K $88.58 K   2.40% 0.06%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 24.28 K $82.56 K   0.00% 0.06%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 23.50 K $79.91 K   100.00% 0.06%
CATALYST FUNDS MANAGEMENT PTY LTD 05/11/2026 23.50 K $79.90 K   100.00% 0.06%
XTX TOPCO LTD 05/15/2026 22.69 K $77.14 K   -40.58% 0.05%
05/14/2026 22.07 K $75.02 K   -4.07% 0.05%
PNC FINANCIAL SERVICES GROUP, INC. 05/08/2026 21.20 K $72.08 K   0.00% 0.05%
BARCLAYS PLC 05/15/2026 19.97 K $67.89 K   188.65% 0.05%
ALGERT GLOBAL LLC 05/14/2026 19.22 K $65.00 K   59.25% 0.05%
OMERS ADMINISTRATION CORP 05/15/2026 18.40 K $62.56 K   100.00% 0.04%
SAGE CAPITAL MANAGEMENT, LLC 04/15/2026 17.98 K $61.13 K   7.33% 0.04%
MILLENNIUM MANAGEMENT LLC 05/15/2026 16.02 K $54.46 K   100.00% 0.04%
KATHMERE CAPITAL MANAGEMENT, LLC 04/28/2026 15.07 K $51.24 K   100.00% 0.04%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 15.07 K $50.00 K   100.00% 0.04%
MORGAN STANLEY 05/15/2026 14.05 K $47.78 K   -20.31% 0.03%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 04/08/2026 13.50 K $46.17 K   -26.23% 0.03%
CLOSE ASSET MANAGEMENT LTD 05/12/2026 11.68 K $40.00 K   0.00% 0.03%
UBS GROUP AG 05/05/2026 11.67 K $39.67 K   353.09% 0.03%
AXQ CAPITAL, LP 05/13/2026 11.33 K $38.51 K   100.00% 0.03%
ALTSHULER SHAHAM LTD 05/18/2026 11.21 K $38.12 K   0.00% 0.03%
GLASS JACOBSON INVESTMENT ADVISORS LLC 04/23/2026 10.54 K $35.84 K   0.00% 0.03%
CITIGROUP INC 05/11/2026 8.99 K $30.56 K   100.00% 0.02%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 05/08/2026 8.83 K $30.01 K   -4.75% 0.02%
JPMORGAN CHASE & CO 05/13/2026 6.39 K $20.96 K   -63.02% 0.02%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 4.32 K $14.70 K   0.16% 0.01%

Oramed Pharmaceuticals, Inc institutional Ownership - FAQ's

During the previous two years, 88 institutional investors and hedge funds held shares of Oramed Pharmaceuticals, Inc. The most heavily invested institutionals were:

BML Capital Management, LLC: 3.17 M

MERCER GLOBAL ADVISORS INC /ADV: 1.91 M

Gem Investment Advisors, LLC: 1.64 M

Murchinson Ltd.: 1.32 M

BOOTHBAY FUND MANAGEMENT, LLC: 600,716

MARSHALL WACE, LLP: 259,611

31.98% of Oramed Pharmaceuticals, Inc stock is owned by institutional investors.

Institutional investors have bought a total of 12.45 M shares in the last 24 months. This purchase volume represents approximately $40.60 M in transactions.